Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline vs Ceftriaxone in Pediatric CABP
NCT01530763Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of ceftaroline fosamil in community-acquired bacterial pneumonia (CAP), sponsored by Forest Laboratories. Started Sep 2012; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
community-acquired bacterial pneumonia (CAP)
Beyond the preview
Go deeper on NCT01530763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530763.